We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
676
PPL Corp
PPL
$26.5B
| $2.71M | 0.01% |
79,965
+17,590
| +28% | +$612K |
|
677
Northern Trust
NTRS
$33.6B
| $2.67M | 0.01% |
21,043
+4,486
| +27% | +$459K |
|
678
Palo Alto Networks
PANW
$293B
| $2.65M | 0.01% |
12,944
-18,458
| -59% | -$3.43M |
|
679
Atmos Energy
ATO
$28.7B
| $2.65M | 0.01% |
17,181
+3,771
| +28% | +$586K |
|
680
Cboe Global Markets
CBOE
$30.3B
| $2.64M | 0.01% |
11,327
+2,482
| +28% | +$553K |
|
681
Huntington Bancshares
HBAN
$35.6B
| $2.64M | 0.01% |
157,582
+34,761
| +28% | +$525K |
|
682
Erasca
ERAS
$6.47B
| $2.63M | 0.01% |
2,074,390
-2,073,043
| -50% | -$2.78M |
|
683
Design Therapeutics
DSGN
$807M
| $2.62M | 0.01% |
777,537
+131,843
| +20% | +$493K |
|
684
CenterPoint Energy
CNP
$27.3B
| $2.59M | 0.01% |
70,604
+15,543
| +28% | +$576K |
|
685
Protara Therapeutics
TARA
$229M
| $2.58M | 0.01% |
851,674
| – | – |
|
686
Live Nation Entertainment
LYV
$42.8B
| $2.58M | 0.01% |
17,049
+3,963
| +30% | +$546K |
|
687
Yum China
YUMC
$16.4B
| $2.57M | 0.01% |
57,505
-45,058
| -44% | -$2.01M |
|
688
Steris
STE
$22.6B
| $2.55M | 0.01% |
10,627
+2,327
| +28% | +$542K |
|
689
Corpay
CPAY
$25.8B
| $2.53M | 0.01% |
7,625
+1,735
| +29% | +$566K |
|
690
Annexon
ANNX
$881M
| $2.53M | 0.01% |
1,053,709
-1,060,987
| -50% | -$2.13M |
|
691
Eversource Energy
ES
$27.2B
| $2.53M | 0.01% |
39,739
+8,751
| +28% | +$539K |
|
692
VeriSign
VRSN
$26.9B
| $2.52M | 0.01% |
8,735
+1,861
| +27% | +$504K |
|
|
BCYC
693
Bicycle Therapeutics
BCYC
$275M
| $2.52M | 0.01% |
362,325
-1,426
| -0.4% | -$11.4K |
|
694
Equity Residential
EQR
$25.2B
| $2.49M | 0.01% |
+36,901
| New | +$2.54M |
|
695
Oric Pharmaceuticals
ORIC
$1.32B
| $2.48M | 0.01% |
+244,368
| New | +$1.64M |
|
696
NetApp
NTAP
$37.6B
| $2.47M | 0.01% |
23,227
-511,169
| -96% | -$48.5M |
|
697
uniQure
QURE
$3.03B
| $2.45M | 0.01% |
175,806
| – | – |
|
698
Kraft Heinz
KHC
$31.4B
| $2.41M | 0.01% |
93,460
+19,760
| +27% | +$548K |
|
699
Capricor Therapeutics
CAPR
$251M
| $2.4M | 0.01% |
241,644
-487,674
| -67% | -$5.15M |
|
700
Church & Dwight Co
CHD
$24B
| $2.38M | 0.01% |
+24,780
| New | +$2.44M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.